Treatment with Danazol for Refractory Thrombocytopenia in Rheumatoid Arthritis
letter
OA: bronze
CC0
⤵ 2 in-corpus citations
AI-generated summary
This study investigated the efficacy of danazol treatment in patients with rheumatoid arthritis experiencing refractory thrombocytopenia.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Journal Article Treatment with Danazol for Refractory Thrombocytopenia in Rheumatoid Arthritis Get access B. DASGUPTA, B. DASGUPTA Rheumatology UnitGuy's Hospital, London SE1 9RT Search for other works by this author on: Oxford Academic PubMed Google Scholar R. GRAHAME R. GRAHAME Rheumatology UnitGuy's Hospital, London SE1 9RT Search for other works by this author on: Oxford Academic PubMed Google Scholar Rheumatology, Volume 28, Issue 6, December 1989, Pages 550–552, https://doi.org/10.1093/rheumatology/28.6.550 Published: 01 December 1989 Article history Received: 18 August 1989 Published: 01 December 1989
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (2)
Cited by (2)
Source provenance
- openalex
- last seen: 2026-05-14T05:57:23.665459+00:00
License: CC0
· commercial use OK